Adherence to prophylactic infusions of factor VIII or factor IX for haemophilia

被引：24
|
作者：
Thornburg, CD [1 ]
Pipe, SW [1 ]
机构：
[1] Univ Michigan, Med Ctr, Womens Hosp, Ann Arbor, MI 48109 USA
来源：
HAEMOPHILIA | 2006年 / 12卷 / 02期
关键词：
D O I：
10.1111/j.1365-2516.2006.01172.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：198 / 199
页数：2
相关论文
共 50 条
  • [21] Perioperative continuous infusions of factor VIII versus factor IX for patients with hemophilia A or B undergoing major surgery
    Tse, Brandon
    Nisenbaum, Rosane
    Floros, Georgina
    Jiwajee, Aziz
    Teitel, Jerome
    Sholzberg, Michelle
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2023, 55 (02) : 273 - 281
  • [22] Bleeding events in people with congenital haemophilia A without factor VIII inhibitors receiving prophylactic factor VIII treatment: A systematic literature review
    Mannucci, Pier Mannuccio
    Kessler, Craig M.
    Germini, Federico
    Nissen, Francis
    Ofori-Asenso, Richard
    Brocchieri, Cristian
    Bendinelli, Sara
    Iorio, Alfonso
    HAEMOPHILIA, 2023, 29 (04) : 954 - 962
  • [23] Factor VIII and IX genotype characterisation of haemophilia patients with transient or permanent inhibitors in Argentina
    Rossetti, L.
    Szurkalo, I.
    Primiani, L.
    Neme, D.
    Candela, M.
    Bianco, R. Perez
    HAEMOPHILIA, 2010, 16 : 77 - 77
  • [24] Rituximab in the treatment of alloimmune factor VIII and IX antibodies in two children with severe haemophilia
    Mathias, M
    Khair, K
    Hann, I
    Liesner, R
    BRITISH JOURNAL OF HAEMATOLOGY, 2004, 125 (03) : 366 - 368
  • [25] Factor VIII companion diagnostic for haemophilia
    Hu, Chunxiao
    Annese, Valerio F.
    Giagkoulovits, Christos
    Barrett, Michael P.
    Cumming, David R. S.
    FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2022, 10
  • [26] Improved cost-effectiveness by pharmacokinetic dosing of factor VIII in prophylactic treatment of haemophilia A
    Carlsson, M
    Berntorp, E
    Bjorkman, S
    Lethagen, S
    Ljung, R
    HAEMOPHILIA, 1997, 3 (02) : 96 - 101
  • [27] Catalytic antibodies to factor VIII in haemophilia A
    Lacroix-Desmazes, S
    Kazatchkine, MD
    Kaveri, SV
    BLOOD COAGULATION & FIBRINOLYSIS, 2003, 14 : S31 - S34
  • [28] Impact of factor VIII half life on prophylactic dosing in children and adults with severe haemophilia A
    Collins, P. W.
    Fischer, K.
    Blanchette, V
    Bjorkman, S.
    Oh, M.
    Schroth, P.
    Fritsch, S.
    Casey, K.
    Spotts, G.
    Ewenstein, B.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 1128 - 1129
  • [29] HEMOPHILIA - FACTOR-VIII AND FACTOR-IX
    HOFFMAN, SH
    JOURNAL OF MEDICAL TECHNOLOGY, 1985, 2 (05): : 319 - 320
  • [30] Modified factor VIII and factor IX recombinant products
    Santagostino, Elena
    Mancuso, Maria Elisa
    HEMASPHERE, 2018, 2 : 185 - 187
12345